Clinical Trial Update: Randomized Evaluation of Radotinib Versus Imatinib in Phase III Study for Efficacy With Chinese Patients (RERISE China) [Phase 3]

View source ↗

Summary

Phase III randomized study evaluating radotinib versus imatinib in Chinese patients with chronic myeloid leukemia, chronic phase. The study status is active but…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia Chronic Phase

Drugs mentioned

• Imatinib (imatinib)
• Radotinib (radotinib)

Snippet

Sponsor: Il-Yang Pharm. Co., Ltd. | Conditions: Chronic Myeloid Leukemia, Chronic Phase | Phase 3 | Status: ACTIVE_NOT_RECRUITING